Dr. Vidal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7945 Wolf River Blvd
Germantown, TN 38138Phone+1 901-683-0055Fax+1 901-685-2969
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2010 - 2013
Tulane University School of MedicineClass of 2008
Certifications & Licensure
TN State Medical License 2014 - 2026
CA State Medical License 2010 - 2025
MS State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer Start of enrollment: 2015 Aug 01
- Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast Start of enrollment: 2019 Jun 21
Publications & Presentations
PubMed
- Symptom Monitoring App Use Associated With Medication Adherence Among Woman Survivors of Breast Cancer on Adjuvant Endocrine Therapy.Rebecca A Krukowski, Xin Hu, Sara Arshad, Janeane N Anderson, Edward Stepanski
JCO Clinical Cancer Informatics. 2024-12-01 - 1 citationsClinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer.Anthony D Elias, Alyse W Staley, Monica Fornier, Gregory A Vidal, Vida Alami
NPJ Breast Cancer. 2024-10-06 - Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.Elisabeth Heath, Gregory Dyson, Jennifer R Ribeiro, Joanne Xiu, Kelsey Poorman
Cancer Research Communications. 2024-10-01
Press Mentions
Is the FDA Making the Right Moves on Clinical Trials?October 21st, 2024- World-Renowned Cancer Experts to Speak at the West Oncology Conference in MemphisDecember 26th, 2022
- West Cancer Center, Memphis Breast Cancer Consortium and Rabble Health Announce New InitiativeJune 29th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
